Abstract: A bag or pouch for receiving discharge from the human body is made of two superposed sheets of synthetic plastics material joined around their edges and has a filter attached to an upper part of an interior surface of one of the walls, there being a hole or slit in the wall to allow gases exiting the filter to pass to the exterior of the bag or pouch, and an intervening wall is included to separate the filter region from the remainder of the interior of the bag or pouch, said wall being characterized by having a series of scattered holes therein, there being from 100 to 300 holes per square inch (155000 to 465000 holes per square meter) and each hole having a maximum dimension of from 130 to 340 microns.
Type:
Grant
Filed:
July 3, 1990
Date of Patent:
December 24, 1991
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Ronald A. Plass, Gerald T. Whiting, Peter L. Steer
Abstract: Arylthioalkylphenylcarboxylic acids are provided which have the structure ##STR1## wherein Ar represents an aryl group including phenyl or naphthyl which may or may not include one or more substituents, X is COOR where R is hydrogen, alkali metal, or lower alkyl, or X is 5-tetrazolyl or ##STR2## wherein R.sup.1 is lower alkyl or aryl, p is 1 to 5, and m is 1 to 4. These compounds are cardiovascular agents which exhibit thromboxane antagonist activity and thus are useful in the treatment of thrombotic and vasospastic diseases.
Abstract: Boronic acid adducts of technetium-.sup.99m imine-dioxime complexes are useful for imaging the myocardium, hepatobiliary system, brain and blood pool in humans and other mammalian species.
Abstract: Novel calcium channel blockers having the formula ##STR1## wherein X is oxygen or sulfur and wherein R, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 are as defined herein, are disclosed. These compounds are useful, for example, as anti-ischemic agents.
Abstract: A method is provided for preventing reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A.sub.2 receptor antagonist.
Type:
Grant
Filed:
April 11, 1988
Date of Patent:
November 19, 1991
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Martin L. Ogletree, William A. Schumacher, Gary J. Grover, Lawrence T. Friedhoff
Abstract: A process for the preparation of the optically active compound [IR-(1.alpha., 2.beta., 3.alpha.)]-2-amino-9-[2,3-bis(hydroxymethyl)cyclobutyl]-6H-purin-6-one, represented by the formula: ##STR1## and novel intermediates are described.
Abstract: Novel compounds are disclosed having the formula ##STR1## and R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6 and R.sub.7 are as defined herein. These compounds are useful, for example, as cardiovascular agents and especially as anti-ischemic agents.
Abstract: A method is provided for slowing the progression of atherosclerosis in coronary arteries in hypertensive or normotensive patients and reducing or eliminating atherosclerotic lesions in such patients in a mammalian species by administering an ACE inhibitor, especially one containing a mercapto moiety, such as captopril or zofenopril.
Type:
Grant
Filed:
October 23, 1989
Date of Patent:
October 29, 1991
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
A. K. Gunnar Aberg, Patricia Ferrer, Miguel A. Ondetti
Abstract: A dressing comprising a flexible backing member and a pressure sensitive adhesive layer. The adhesive layer comprises one or more polyisobutylenes, elastomers, and one or more moisture absorbing, moisture transmitting, water soluble and/or water swellable agents. A dispersion of the active ingredient in a medium compatible with the adhesive layer is laminated to the skin contacting surface.
Type:
Grant
Filed:
September 8, 1987
Date of Patent:
October 22, 1991
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Rodolfo D. Cilento, Margaret A. Frank, John E. Fairbrother, Frank M. Freeman
Abstract: Antiviral activity is exhibited by compounds having the formula ##STR1## and pharmaceutically acceptable salts thereof wherein R.sub.1 is a purine or pyrimidine base or an analog thereof and R.sub.2 and R.sub.3 are independently hydrogen, --PO.sub.3 H.sub.2 or ##STR2## wherein X.sub.7 is hydrogen, alkyl, substituted alkyl or aryl.
Abstract: A process is disclosed for providing benzazepine intermediates of the formulae ##STR1## wherein R.sub.3, R.sub.4 and Y are as defined herein, which intermediates are useful in a process for the preparation of pharmaceutically useful benzazepine derivatives.
Type:
Grant
Filed:
November 29, 1989
Date of Patent:
October 1, 1991
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Wen-Sen Li, John K. Thottathil, Michael Murphy
Abstract: Antihypercholesterolemic activity is exhibited by novel compounds of the formula ##STR1## wherein: Z is ##STR2## X is lower alkyl or lower alenyl; R.sup.1 is aryl or alkyl;R.sup.2 and R.sup.3 are the same or different and are hydrogen, or lower alkyl or aryl, or R.sup.2 and R.sup.3 taken together to form a cycloalkyl group; andR.sup.4 is hydrogen, lower alkyl, or alkali metal (such as sodium, lithium, or potassium) or a radical such as ammonium.Methods of use and novel intermediates of these compounds are also provided.
Abstract: A pharmaceutical composition in the form of beads prepared by an extrusion-spheronization technique and containing more than 80% by weight drug, less than 15% by weight non-lipophilic binder-plasticizer, such as microcrystalline cellulose to achieve required plasticity for processing, a starch-based excipient such as sodium starch glycolate or pregelatinized starch to control water/fluid distribution and thereby inhibit agglomeration during processing, and water-soluble binder such as hydrolyzed gelatin to make the final beads less friable. During processing a granulating agent such as ethanol/water is added to improve blend properties and control during spheronization. A method for preparing the above beads is also provided.
Abstract: A method is provided for preventing onset of or treating symptoms resulting from closed head injuries, in hypertensive or normotensive patients, by administering an ACE inhibitor, for example captopril, zofenopril, fosinopril, ceranapril, enalapril or lisinopril.
Abstract: Antihypercholesterolemic activity has been discovered in compounds of the formula ##STR1## and pharmaceutically acceptable salts thereof, wherein: Z is ##STR2## X is lower alkyl, lower alkenyl, or lower alkenyl; R.sup.1 is hydrogen, alkyl, alkenyl, aryl, alkylaryl, or substituted aryl having one or more substituents; andone of R.sup.2 and R.sup.3 is hydrogen and the other is hydrogen, alkyl, alkenyl, aryl, alkylaryl or alkenyl aryl; or R.sup.2 and R.sup.3 are both lower alkyl; or R.sup.2 and R.sup.3 together complete a substituted or unsubstituted hydrocarbon ring that is cycloalkyl or cycloalkenyl with substituents as defined in the specification.
Type:
Grant
Filed:
January 29, 1990
Date of Patent:
September 17, 1991
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Ravi K. Varma, Eric M. Gordon, Sam T. Chao
Abstract: Derivatives of pravastatin are provided which are useful in inhibiting cholesterol biosynthesis and in preparing radiolabeled compounds useful in the radioimmunoassay (RIA) of pravastatin and derivatives thereof. The pravastatin derivatives have the structure ##STR1## wherein R is hydroxy, lower alkylamine, arylamine, arylalkylamine or heterocyclic alkylamine such as histamine, tyramine, O-benzyltyramine, methyl tyrosinate as well as iodinated derivatives thereof.
Type:
Grant
Filed:
April 17, 1989
Date of Patent:
September 10, 1991
Assignee:
E. R. Squibb & Sons, Inc.
Inventors:
Richard A. DiPietro, Jan-I Tu, Noor Z. Turabi
Abstract: A coupling element system for an ostomy bag including a bag-side coupling element having a stomal orifice surrounded by a channel shaped member, a body-side coupling element having a stomal orifice surrounded by a rib-like member which can make snap-fit engagement with the channel shaped member, and a locking member. The latter member has radially inwardly deformable arms and is rotatable relative to the body-side coupling. The deformable arms are shaped and positioned so that upon rotation of the locking member in one rotary direction relative to the body-side coupling element they are deformed radially inwardly and over-lie a portion of the bag-side coupling element.The locking member may be generally annular with the arms arcuate in shape each with a blade portion and a leg portion which connects the blade portion to the remainder of the locking member.